Home › Trial NCT06292780
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
- Trial IDNCT06292780
- StatusRecruiting
- PhasePhase 1/2
- Study typeInterventional
- SponsorRegeneron Pharmaceuticals
- Enrollment220
- Start date2024-08-07
- ConditionsRelapsed/Refractory Systemic Light Chain Amyloidosis
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.